People who take statins usually see their 'bad' cholesterol go down by about a quarter to a third, and most don’t have serious side effects, according to big medical studies.
Claim Context
Statins are associated with a 25–35% reduction in plasma LDL cholesterol levels in patients with hypercholesterolemia, based on consistent results from large-scale clinical trials involving approximately 90,000 subjects followed for 5 years, with minimal major adverse effects reported across studies.
“Statins have now been tested in many large-scale clinical trials, involving 90,000 subjects who were followed for 5 years. The results in all these studies have been consistent: treatment with statins lowers plasma LDL levels by 25–35% and reduces the frequency of heart attacks by 25–30%.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Provide the most reliable estimate of the average LDL-lowering effect of statins across diverse populations and dosages.
A Cochrane systematic review and meta-analysis of 30+ double-blind RCTs comparing any statin to placebo in adults with hypercholesterolemia, pooling data on baseline and post-treatment LDL levels, calculating mean difference and 95% confidence intervals, with subgroup analyses by statin type, dose, and patient characteristics.
Demonstrate the causal effect of statin therapy on LDL cholesterol reduction under controlled conditions.
A multicenter, double-blind RCT of 5,000 adults aged 45–75 with LDL >130 mg/dL, randomized to atorvastatin 40 mg/day vs placebo for 6 months, with primary outcome: change in LDL cholesterol measured by standardized lipid panel at baseline, 3, and 6 months.
Show how much LDL drops in real-world patients taking statins over time.
A prospective cohort study following 20,000 patients newly prescribed statins in primary care settings for 2 years, tracking LDL levels at initiation, 6, 12, and 24 months, adjusting for age, sex, baseline LDL, and concomitant medications.
Estimate the current association between statin use and LDL levels in a population.
A national health examination survey testing LDL cholesterol in 15,000 adults, comparing levels between current statin users and non-users, stratified by age, sex, and cardiovascular risk category.
Summarize existing knowledge and provide context for clinical application.
A narrative review by lipid metabolism experts summarizing key trials, guidelines, and mechanisms of statin action, intended for clinician education.